Connection
David Bentley to Deoxycytidine
This is a "connection" page, showing publications David Bentley has written about Deoxycytidine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.085 |
|
|
|
-
Waddell T, Gollins S, Soe W, Valle J, Allen J, Bentley D, Morris J, Lloyd A, Swindell R, Taylor MB, Saunders MP. Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study. Cancer Chemother Pharmacol. 2011 May; 67(5):1111-7.
Score: 0.085